Company Filing History:
Years Active: 2001
Title: Pär Alejung: Innovator in Gastrointestinal Health
Introduction
Pär Alejung is a notable inventor based in Lund, Sweden, recognized for his contribution to the field of gastrointestinal health. With a focus on innovative oral preparations, Alejung's work addresses the therapeutic needs associated with Helicobacter sp. infections, which are known to cause significant inflammation in the gastrointestinal tract, particularly within the human stomach.
Latest Patents
Pär Alejung holds a patent for an "Oral preparation for the prophylactic and therapeutic treatment of Helicobacter sp. infection." This groundbreaking formulation includes a prophylactically and therapeutically effective amount of xanthophylls, with a strong preference for astaxanthin. This compound is naturally produced and is particularly effective when esterified with fatty acids. The preparation also considers the inclusion of carbohydrate structures derived from the cell wall of the alga Haematococcus sp. Additionally, it can contain water-soluble antioxidants like ascorbic acid, commonly known as vitamin C, enhancing its therapeutic potential. This oral preparation may be offered as a separate unit dose or conveniently mixed with food.
Career Highlights
Pär Alejung is currently affiliated with Astacarotene AB, a company that focuses on developing carotenoid-based health products. His dedication to research and innovative product development has positioned him as a key figure within his organization, emphasizing gastrointestinal health solutions.
Collaborations
Throughout his career, Alejung has collaborated with various professionals in his field, notably Torkel Wadström, contributing to the advancement of research aimed at combating Helicobacter sp. infections. Their partnership has enabled significant insights and developments in therapeutic options, enhancing patient care strategies.
Conclusion
Pär Alejung's innovative approach to creating effective oral preparations against Helicobacter sp. infections marks a significant advancement in gastrointestinal health. His contributions not only showcase his inventive spirit but also his commitment to improving therapeutic options for patients affected by such infections. As the landscape of medical innovation continues to evolve, Alejung's work exemplifies the vital interplay between ingenuity and health solutions.